1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Verrica Parmaceuticals Inc (VRCA)
  7. Quote


Verrica Parmaceuticals Stock Price

-0.14 (-1.49%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 91,391
Bid Price 8.50
Ask Price 11.00
News -
Day High 9.7555


52 Week Range


Day Low 9.02
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Verrica Parmaceuticals Inc VRCA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.14 -1.49% 9.26 20:00:00
Open Price Low Price High Price Close Price Prev Close
9.42 9.02 9.7555 9.26 9.40
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,786 91,391 $ 9.22 $ 842,992 - 8.51 - 18.42
Last Trade Time Type Quantity Stock Price Currency
18:03:28 3 $ 9.26 USD


Draw Mode:

Verrica Parmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 254.83M 27.52M 13.03M $ - $ - -1.71 -6.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 40.60%

more financials information »

Verrica Parmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRCA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.9511.408.5110.13118,568-1.69-15.43%
1 Month13.2013.5358.5111.1262,615-3.94-29.85%
3 Months12.3813.648.5111.69116,847-3.12-25.2%
6 Months9.9014.7898.5111.5698,285-0.64-6.46%
1 Year9.4018.428.5112.3197,750-0.14-1.49%
3 Years12.1818.675.7611.2087,125-2.92-23.97%
5 Years20.0023.295.7611.7484,599-10.74-53.7%

Verrica Parmaceuticals Description

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Your Recent History
Verrica Pa..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.